Tandem Diabetes Care Inc

TD5A

Company Profile

  • Business description

    Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

  • Contact

    12400 High Bluff Drive
    San DiegoCA92130
    USA

    T: +1 858 366-6900

    E: [email protected]

    https://www.tandemdiabetes.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    2,650

Stocks News & Analysis

stocks

Earnings losers: TWE, GMG, SUN and more fall on weaker profits

Where companies fell short of market expectations in the third week of earnings.
stocks

Overvalued ASX listed gold miner reports lower profit

Shares remain materially overvalued.
stocks

ASX healthcare leader still undervalued after rally

Our view following announcement of potential spinoff.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,247.3087.30-0.94%
CAC 408,515.49116.711.39%
DAX 4025,260.69217.120.87%
Dow JONES (US)49,588.98193.820.39%
FTSE 10010,686.8959.850.56%
HKSE27,019.21605.862.29%
NASDAQ22,875.73193.000.85%
Nikkei 22556,825.70642.13-1.12%
NZX 50 Index13,420.43111.910.84%
S&P 5006,905.3643.470.63%
S&P/ASX 2009,020.6089.50-0.98%
SSE Composite Index4,082.0751.95-1.26%

Market Movers